Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Rhythm Pharmaceuticals Inc.’s stock clocked out at $49.62, up 0.63% from its previous closing price of $49.31. In other words, the price has increased by $0.63 from its previous closing price. On the day, 0.72 million shares were traded. RYTM stock price reached its highest trading level at $50.0 during the session, while it also had its lowest trading level at $49.3.
Ratios:
To gain a deeper understanding of RYTM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.31 and its Current Ratio is at 6.53. In the meantime, Its Debt-to-Equity ratio is 6.42 whereas as Long-Term Debt/Eq ratio is at 6.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on May 08, 2024, Downgraded its rating to Neutral and sets its target price to $42 from $49 previously.
On December 19, 2023, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $29 to $55.
BofA Securities Upgraded its Neutral to Buy on August 01, 2023, whereas the target price for the stock was revised from $22 to $27.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 09 ’24 when Cramer Pamela J. sold 4,099 shares for $50.03 per share. The transaction valued at 205,062 led to the insider holds 13,500 shares of the business.
TETRAULT LYNN A. sold 17,501 shares of RYTM for $868,923 on Sep 10 ’24. The Director now owns 3,000 shares after completing the transaction at $49.65 per share. On Sep 09 ’24, another insider, TETRAULT LYNN A., who serves as the Director of the company, sold 3,199 shares for $50.04 each. As a result, the insider received 160,068 and left with 3,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RYTM now has a Market Capitalization of 3033459200 and an Enterprise Value of 2966968320. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.80 while its Price-to-Book (P/B) ratio in mrq is 77.06. Its current Enterprise Value per Revenue stands at 29.15 whereas that against EBITDA is -11.241.
Stock Price History:
Over the past 52 weeks, RYTM has reached a high of $53.92, while it has fallen to a 52-week low of $20.97. The 50-Day Moving Average of the stock is 5.18%, while the 200-Day Moving Average is calculated to be 15.33%.
Shares Statistics:
It appears that RYTM traded 464.94K shares on average per day over the past three months and 407660 shares per day over the past ten days. A total of 59.43M shares are outstanding, with a floating share count of 54.56M. Insiders hold about 10.76% of the company’s shares, while institutions hold 104.35% stake in the company. Shares short for RYTM as of 1724976000 were 9642786 with a Short Ratio of 20.74, compared to 1722384000 on 10182467. Therefore, it implies a Short% of Shares Outstanding of 9642786 and a Short% of Float of 23.91.
